Oncoliq

Late cancer detection leads to death. Today, 50% of cancer diagnoses are late, meaning that most of these people die within 5 years. Oncoliq's mission is to reduce cancer-caused deaths globally through an early detection approach. Their solution is a blood test that detects up to 50 cancer types. They combine molecular biology strategies based on PCR with machine learning, to develop algorithms that indicate whether a person has a tumor in a specific organ. Oncoliq’s technology is highly sensitive, non-toxic, non-invasive and low cost.